EP 0536741 B1 19951227 - Cyclic VIP analogs
Title (en)
Cyclic VIP analogs
Title (de)
Zyklische VIP-Analoge
Title (fr)
Analogues cycliques de VIP
Publication
Application
Priority
US 77374791 A 19911011
Abstract (en)
[origin: EP0536741A2] The present invention relates to vasoactive peptide (VIP) analogs wherein the side chain carboxy terminus of one amino acid in the peptide chain is attached covalently to the side chain amino terminus of another amino acid in the peptide chain via the formation of an amide bond. The covalent bonding between the two amino acid residues in the peptide chain yields a ring structure. The present invention provides cyclic vasoactive peptides and pharmaceutical compositions comprising such a cyclic vasoactive peptide for the treatment of bronchotracheal constrictive disorders.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/08 (2019.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61P 11/08 (2006.01); A61P 21/02 (2006.01); C07K 7/54 (2006.01); C07K 14/00 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C07K 14/575 (2006.01)
IPC 8 main group level
C07K (2006.01)
CPC (source: EP KR US)
A61P 11/08 (2018.01 - EP); A61P 21/02 (2018.01 - EP); C07K 14/46 (2013.01 - KR); C07K 14/57563 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); Y10S 930/17 (2013.01 - EP US); Y10S 930/27 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
EP 0536741 A2 19930414; EP 0536741 A3 19940406; EP 0536741 B1 19951227; AT E132165 T1 19960115; AU 2622892 A 19930422; AU 656230 B2 19950127; BG 61125 B2 19961129; BR 9203959 A 19930427; CA 2080272 A1 19930412; CA 2080272 C 20020917; CN 1034943 C 19970521; CN 1072415 A 19930526; CN 1152579 A 19970625; CN 1153785 A 19970709; CN 1198841 C 20050427; CN 1225473 C 20051102; CZ 281818 B6 19970212; CZ 308692 A3 19930811; DE 69207138 D1 19960208; DE 69207138 T2 19960613; DK 0536741 T3 19960422; ES 2082317 T3 19960316; FI 111646 B 20030829; FI 20002041 A 20000915; FI 924580 A0 19921009; FI 924580 A 19930412; GR 3019326 T3 19960630; HU 211534 A9 19951228; HU 9203194 D0 19921228; HU T62606 A 19930528; IL 103396 A0 19930315; IL 103396 A 19971120; IL 117252 A0 19960618; IL 117252 A 19991130; JP 2515473 B2 19960710; JP H05213996 A 19930824; KR 930007972 A 19930520; KR 970001580 B1 19970211; MX 9205822 A 19930601; NO 304523 B1 19990104; NO 923929 D0 19921009; NO 923929 L 19930413; NO 975023 D0 19971031; NO 975023 L 19930413; NO 980377 D0 19980128; NO 980377 L 19930413; NZ 244644 A 19950427; RU 2095368 C1 19971110; SK 279399 B6 19981104; SK 308692 A3 19950308; TW 305846 B 19970521; US 5677419 A 19971014; UY 23488 A1 19930420; UY 25084 A1 19981221; ZA 927724 B 19940407
DOCDB simple family (application)
EP 92117185 A 19921008; AT 92117185 T 19921008; AU 2622892 A 19921006; BG 9860894 A 19940228; BR 9203959 A 19921013; CA 2080272 A 19921009; CN 92113069 A 19921010; CN 96111523 A 19960815; CN 96111807 A 19960815; CS 308692 A 19921009; DE 69207138 T 19921008; DK 92117185 T 19921008; ES 92117185 T 19921008; FI 20002041 A 20000915; FI 924580 A 19921009; GR 960400712 T 19960315; HU 9203194 A 19921009; HU 9500297 P 19950621; IL 10339692 A 19921009; IL 11725292 A 19921009; IL 11725296 A 19960223; JP 29783592 A 19921009; KR 920018660 A 19921010; MX 9205822 A 19921009; NO 923929 A 19921009; NO 975023 A 19971031; NO 980377 A 19980128; NZ 24464492 A 19921007; SK 308692 A 19921009; SU 5053217 A 19921008; TW 81107995 A 19921008; US 30872994 A 19940919; UY 23488 A 19921009; UY 25084 A 19980706; ZA 927724 A 19921007